Catatonia in Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Misdiagnosed as Schizophrenia

Authors

  • André Ponte Hospital Júlio de Matos. Centro Hospitalar Psiquiátrico de Lisboa. Lisboa. Clínica Universitária de Psiquiatria e Psicologia Médica. Faculdade de Medicina. Universidade de Lisboa. Lisboa.
  • Ana Brito Hospital Santo António dos Capuchos. Centro Hospitalar Lisboa Central. Lisboa.
  • Camila Nóbrega Hospital Júlio de Matos. Centro Hospitalar Psiquiátrico de Lisboa. Lisboa.
  • Sofia Pinheiro Hospital Santo António dos Capuchos. Centro Hospitalar Lisboa Central. Lisboa.
  • João Gama Marques Hospital Júlio de Matos. Centro Hospitalar Psiquiátrico de Lisboa. Lisboa. Clínica Universitária de Psiquiatria e Psicologia Médica. Faculdade de Medicina. Universidade de Lisboa. Lisboa.

DOI:

https://doi.org/10.20344/amp.11077

Keywords:

Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Catatonia, Psychosis, Schizophrenia

Abstract

Anti-N-Mmethyl-D-aspartate receptor encephalitis is an autoimmune disease of the central nervous system with prominent neurologic and psychiatric features. Symptoms appear progressively and sometimes with an exclusively psychiatric initial presentation. The patient’s evaluation should be meticulous, and we should use all the diagnostic tests required for the exclusion of entities that can mimic this disease. We report the diagnostic investigation of a case of anti-N-methyl-D-aspartate receptor encephalitis in a patient with a previous diagnosis of schizophrenia with poor response to antipsychotics. The aim of this case report is to highlight the importance of close surveillance for neuropsychiatric symptoms, especially catatonia, and to recognize autoimmune encephalitis in the differential diagnosis of psychotic disorders with neurological symptoms and resistance or intolerance to antipsychotics. A prompt diagnosis will contribute to a faster onset of therapy and an overall improvement in prognosis.

Downloads

Downloads

Published

2020-03-02

How to Cite

1.
Ponte A, Brito A, Nóbrega C, Pinheiro S, Gama Marques J. Catatonia in Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Misdiagnosed as Schizophrenia. Acta Med Port [Internet]. 2020 Mar. 2 [cited 2025 Apr. 6];33(3):208-11. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/11077

Issue

Section

Case Report
Crossref
9
Scopus
9
Luís Silva Gadelho, João Gama Marques (2022)
Catatonia associated with epileptic seizures: A systematic review of case reports. Epilepsy Research, 186, 107016.
10.1016/j.eplepsyres.2022.107016
João Gama Marques (2023)
Schizophrenia Misdiagnosis after Capgras and Cotard Delusions in a Patient with Infantile Cystinosis, Cavum Septi Pellucidi, Cavum Vergae and Cavum Veli Interpositi. Behavioral Sciences, 13(2), 157.
10.3390/bs13020157
Hai-Yang Wang, Xiao-Yu Yang, Jinming Han, Huakun Liu, Zhong-Rui Yan, Zhanhua Liang (2022)
Clinical characteristics of anti-N-methyl-d-aspartate receptor encephalitis in patients with a long-term history of mental disorders. European Journal of Medical Research, 27(1),
10.1186/s40001-022-00664-5
Vladimir D. Mendelevich, Konstantin S. Sergienko, Kausar K. Yakhin, Elvira A. Abdullina (2024)
Anti-NMDA receptor encephalitis fatal case was mistaken as a debut of schizophrenia: the devil is in the psychopathological details. Neurology Bulletin, LVI(3), 299.
10.17816/nb633510
João Costa Fernandes, João Gama Marques (2022)
A scoping review on paraneoplastic autoimmune limbic encephalitis (PALE) psychiatric manifestations. CNS Spectrums, 27(2), 191.
10.1017/S1092852920001960
João Gama Marques (2024)
Never Forget About Catatonia Secondary to Organic Conditions. The Journal of ECT, 40(3), 217.
10.1097/YCT.0000000000001015
Denis Pavăl, Nicoleta Gherghel-Pavăl, Octavia Oana Căpățînă, Adina Stan, Ioana Valentina Micluția (2024)
The relevance of anti-N-methyl-D-aspartate receptor encephalitis for psychiatrists. International Journal of Psychiatry in Clinical Practice, 28(1), 73.
10.1080/13651501.2024.2323926
João Gama Marques (2020)
Secondary catatonia: An often overlooked diagnosis. Clinical Neurology and Neurosurgery, 196, 106012.
10.1016/j.clineuro.2020.106012
João Gama Marques, Josef Finsterer (2025)
Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 45(2), 145.
10.1002/phar.4647
Mendelevich V.D. (2024)
Recurrence of schizophreniform psychosis, coincident with the detection of ovarian tumors. The case of 30-year-old patient. Clinical Review for General Practice, 5(12), 80-88.
10.47407/kr2024.5.12.00541